Biogen: Number of Employees 2010-2022 | BIIB
Interactive chart of Biogen (BIIB) annual worldwide employee count from 2010 to 2022.
- Biogen total number of employees in 2021 was 9,610, a 5.6% increase from 2020.
- Biogen total number of employees in 2020 was 9,100, a 22.97% increase from 2019.
- Biogen total number of employees in 2019 was 7,400, a 5.13% decline from 2018.
- Biogen total number of employees in 2018 was 7,800, a 6.85% increase from 2017.
| Biogen Annual Number of Employees |
| 2021 |
9,610 |
| 2020 |
9,100 |
| 2019 |
7,400 |
| 2018 |
7,800 |
| 2017 |
7,300 |
| 2016 |
7,400 |
| 2015 |
7,350 |
| 2014 |
7,550 |
| 2013 |
6,850 |
| 2012 |
5,950 |
| 2011 |
5,000 |
| 2010 |
4,850 |
| 2009 |
4,750 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$30.056B |
$10.982B |
|
Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement disorders including Parkinson's disease, neuromuscular disorders, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS) and ophthalmology. Key multiple sclerosis/MS drugs in its portfolio are Tecfidera, Vumerity, Avonex, Plegridy, Fampyra and Tysabri. Other approved/marketed products include Fumaderm (severe psoriasis), Spinraza (spinal muscular atrophy (SMA)) and Aduhelm (Alzheimer's disease).
|
